WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Sean Anderson
Associate
Litigation
Century City
sean.anderson@wsgr.com

D424-446-6941

Download vCard
Open PDF

Sean Anderson is an associate in Wilson Sonsini Goodrich & Rosati’s Century City office, where he is a member of the patent litigation group. His practice focuses on intellectual property litigation, with an emphasis on pharmaceutical patent litigation under the Hatch-Waxman Act. Sean has represented clients as both plaintiffs and defendants in a variety of complex technology areas, including pharmaceuticals, medical methods, medical devices, and consumer electronics.  

Prior to joining the firm, Sean was an associate in the intellectual property group at Atkinson, Andelson, Loya, Ruud & Romo, where he represented clients in intellectual property matters, including patent, trademark, and trade secret litigation. He also advised employers in a broad range of industries on issues relating to employee mobility and restrictive covenants. Sean was previously an associate in the patent litigation group at Goodwin Procter, where he represented life science and technology companies in patent and trade secret litigation. Prior to law school, Sean worked as a bioprocess manufacturing technician at Genentech.

In addition to his commercial work, Sean is actively involved in pro bono work. He has represented clients in immigration matters and provided guidance to nonprofit organizations and small businesses on intellectual property-related matters. In law school, Sean was a student attorney in Boston University’s BU/MIT Startup Law Clinic, which offers pro bono legal services to early-stage Boston University and MIT start-ups.

Experience

Sean Anderson is an associate in Wilson Sonsini Goodrich & Rosati’s Century City office, where he is a member of the patent litigation group. His practice focuses on intellectual property litigation, with an emphasis on pharmaceutical patent litigation under the Hatch-Waxman Act. Sean has represented clients as both plaintiffs and defendants in a variety of complex technology areas, including pharmaceuticals, medical methods, medical devices, and consumer electronics.  

Prior to joining the firm, Sean was an associate in the intellectual property group at Atkinson, Andelson, Loya, Ruud & Romo, where he represented clients in intellectual property matters, including patent, trademark, and trade secret litigation. He also advised employers in a broad range of industries on issues relating to employee mobility and restrictive covenants. Sean was previously an associate in the patent litigation group at Goodwin Procter, where he represented life science and technology companies in patent and trade secret litigation. Prior to law school, Sean worked as a bioprocess manufacturing technician at Genentech.

In addition to his commercial work, Sean is actively involved in pro bono work. He has represented clients in immigration matters and provided guidance to nonprofit organizations and small businesses on intellectual property-related matters. In law school, Sean was a student attorney in Boston University’s BU/MIT Startup Law Clinic, which offers pro bono legal services to early-stage Boston University and MIT start-ups.

Education
  • J.D., Boston University School of Law, 2019

    Student Attorney, BU/MIT Startup Law Clinic; Editor, Journal of Science and Technology Law

  • B.S. Chemical Engineering, University of California, San Diego, 2015

    Undergraduate Researcher, Jacobs School of Engineering Nanosensors Laboratory

Admissions
  • State Bar of California
  • State Bar of New York
  • U.S. District Court for the Central District of California
  • U.S. District Court for the Northern District of California
  • U.S. District Court for the Eastern District of Wisconsin
Credentials
Education
  • J.D., Boston University School of Law, 2019

    Student Attorney, BU/MIT Startup Law Clinic; Editor, Journal of Science and Technology Law

  • B.S. Chemical Engineering, University of California, San Diego, 2015

    Undergraduate Researcher, Jacobs School of Engineering Nanosensors Laboratory

Admissions
  • State Bar of California
  • State Bar of New York
  • U.S. District Court for the Central District of California
  • U.S. District Court for the Northern District of California
  • U.S. District Court for the Eastern District of Wisconsin

Select Matters

  • Following three-week trial, secured $176.5 million willful patent infringement jury verdict for Teva Pharmaceuticals. The jury found that Eli Lilly’s Emgality® (galcanezumab) product infringed Teva patents covering a method of treating migraine using anti-CGRP antagonist antibodies. (District of Massachusetts)
  • Secured defense jury verdict of patent invalidity due to obviousness for Pass & Seymour in dispute over Pass & Seymour’s core GFCI technology between the two market leaders in the U.S. GFCI market (Eastern District of New York)*
  • Obtained favorable settlement for Contractors Wardrobe following Markman hearing in litigation involving patents covering a water deflection system (Central District of California)*
  • Represented Novartis in ITC investigation and related patent litigations involving Novartis’s pre-filled syringe patent against Regeneron’s blockbuster EYLEA® (aflibercept) product (ITC and Northern District of New York)*

*Denotes matters handled at another firm prior to joining Wilson Sonsini

Matters

Select Matters

  • Following three-week trial, secured $176.5 million willful patent infringement jury verdict for Teva Pharmaceuticals. The jury found that Eli Lilly’s Emgality® (galcanezumab) product infringed Teva patents covering a method of treating migraine using anti-CGRP antagonist antibodies. (District of Massachusetts)
  • Secured defense jury verdict of patent invalidity due to obviousness for Pass & Seymour in dispute over Pass & Seymour’s core GFCI technology between the two market leaders in the U.S. GFCI market (Eastern District of New York)*
  • Obtained favorable settlement for Contractors Wardrobe following Markman hearing in litigation involving patents covering a water deflection system (Central District of California)*
  • Represented Novartis in ITC investigation and related patent litigations involving Novartis’s pre-filled syringe patent against Regeneron’s blockbuster EYLEA® (aflibercept) product (ITC and Northern District of New York)*

*Denotes matters handled at another firm prior to joining Wilson Sonsini

Select Publications

  • Editor, Business Law Journal, April 2023 – June 2024
  • Blog Editor, Big Molecule Watch, January 2020 – March 2023
  • Co-author, “Idenix v. Gilead: The enablement and written description limits of a genus claim,” 17(2) Journal of Generic Medicines, June 2021
  • Co-author, “Solid-state Forensic Finger sensor for integrated sampling and detection of gunshot residue and explosives: towards ‘Lab-on-a-finger,’” 138 Analyst 5288–5295, 2013

Select Speaking Engagements

  • “Wave Hopping and Wipeouts: Employee Mobility and Restrictive Covenants,” 2024 Employment Law Conference, March 2024
  • “Trade Secrets and Employee Mobility in California,” 2023 Construction Legal Forum, November 2023
  • “The Intersection of Artificial Intelligence and Intellectual Property,” AALRR Workplace Wednesday Webinar, November 2023
  • “The Intersection of HR and Intellectual Property – Part One,” AALRR Workplace Wednesday Webinar, October 2023
Insights

Select Publications

  • Editor, Business Law Journal, April 2023 – June 2024
  • Blog Editor, Big Molecule Watch, January 2020 – March 2023
  • Co-author, “Idenix v. Gilead: The enablement and written description limits of a genus claim,” 17(2) Journal of Generic Medicines, June 2021
  • Co-author, “Solid-state Forensic Finger sensor for integrated sampling and detection of gunshot residue and explosives: towards ‘Lab-on-a-finger,’” 138 Analyst 5288–5295, 2013

Select Speaking Engagements

  • “Wave Hopping and Wipeouts: Employee Mobility and Restrictive Covenants,” 2024 Employment Law Conference, March 2024
  • “Trade Secrets and Employee Mobility in California,” 2023 Construction Legal Forum, November 2023
  • “The Intersection of Artificial Intelligence and Intellectual Property,” AALRR Workplace Wednesday Webinar, November 2023
  • “The Intersection of HR and Intellectual Property – Part One,” AALRR Workplace Wednesday Webinar, October 2023
Focus Areas
  • Biotech
  • Intellectual Property
  • Life Sciences
  • Litigation
  • Medical Devices
  • Patent Litigation
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.